Sugar for the brain: The role of glucose in physiological and pathological brain function

Trends in Neurosciences

Volumn 36, Issue 10, 2013, Pages 587-597

  Mergenthaler, Philipp ^a   Lindauer, Ute ^b   Dienel, Gerald A ^c   Meisel, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Apoptosis; Brain body axis; Glucose metabolism; Metabolic brain disease; Metabolic coupling

Indexed keywords

GLUCOSE; LACTIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

ALZHEIMER DISEASE; APOPTOSIS; ASTROCYTE; BIOENERGY; BRAIN FUNCTION; CELL DEATH; CELL INTERACTION; ENERGY RESOURCE; FUNCTIONAL NEUROIMAGING; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; LACTATE BLOOD LEVEL; METABOLIC REGULATION; MULTIINFARCT DEMENTIA; NERVE CELL; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

APOPTOSIS; BRAIN-BODY AXIS; GLUCOSE METABOLISM; METABOLIC BRAIN DISEASE; METABOLIC COUPLING;

ANIMALS; BRAIN; ENERGY METABOLISM; GLUCOSE; HUMANS;

EID: 84884815400     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2013.07.001     Document Type: Review

References (109)

1. Howarth C., et al. Updated energy budgets for neural computation in the neocortex and cerebellum. J. Cereb. Blood Flow Metab. 2012, 32:1222-1232.
2. Erbsloh F., et al. [The glucose consumption of the brain & its dependence on the liver]. Arch. Psychiatr. Nervenkr. Z. Gesamte Neurol. Psychiatr. 1958, 196:611-626.
3. Harris J.J., et al. Synaptic energy use and supply. Neuron 2012, 75:762-777.
4. Ivannikov M.V., et al. Calcium clearance and its energy requirements in cerebellar neurons. Cell Calcium 2010, 47:507-513.
5. Dienel G.A. Fueling and imaging brain activation. ASN Neuro 2012, 4:e00093.
6. Hertz L., Gibbs M.E. What learning in day-old chickens can teach a neurochemist: focus on astrocyte metabolism. J. Neurochem. 2009, 109(Suppl. 1):10-16.
7. Suzuki A., et al. Astrocyte-neuron lactate transport is required for long-term memory formation. Cell 2011, 144:810-823.
8. Lauritzen K.H., et al. Lactate receptor sites link neurotransmission, neurovascular coupling, and brain energy metabolism. Cereb. Cortex 2013, 10.1093/cercor/bht136.
9. Bergersen L.H., Gjedde A. Is lactate a volume transmitter of metabolic states of the brain?. Front. Neuroenerget. 2012, 4:5.
10. Alle H., et al. Energy-efficient action potentials in hippocampal mossy fibers. Science 2009, 325:1405-1408.
11. Liotta A., et al. Energy demand of synaptic transmission at the hippocampal Schaffer-collateral synapse. J. Cereb. Blood Flow Metab. 2012, 32:2076-2083.
12. Harris J.J., Attwell D. The energetics of CNS white matter. J. Neurosci. 2012, 32:356-371.
13. Sokoloff L. Energetics of functional activation in neural tissues. Neurochem. Res. 1999, 24:321-329.
14. van Hall G., et al. Blood lactate is an important energy source for the human brain. J. Cereb. Blood Flow Metab. 2009, 29:1121-1129.
15. Lutas A., Yellen G. The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci. 2013, 36:32-40.
16. Simpson I.A., et al. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J. Cereb. Blood Flow Metab. 2007, 27:1766-1791.
17. Gandhi G.K., et al. Astrocytes are poised for lactate trafficking and release from activated brain and for supply of glucose to neurons. J. Neurochem. 2009, 111:522-536.
18. Rouach N., et al. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 2008, 322:1551-1555.
19. Wilson J.E. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J. Exp. Biol. 2003, 206:2049-2057.
20. Borgstrom L., et al. Glucose consumption in the cerebral cortex of rat during bicuculline-induced status epilipticus. J. Neurochem. 1976, 27:971-973.
21. Lowry O.H., et al. Effect of ischemia on known substrates and cofactors of the glycolytic pathway in brain. J. Biol. Chem. 1964, 239:18-30.
22. Dienel G.A. Brain lactate metabolism: the discoveries and the controversies. J. Cereb. Blood Flow Metab. 2012, 32:1107-1138.
23. Dienel G.A., et al. A glycogen phosphorylase inhibitor selectively enhances local rates of glucose utilization in brain during sensory stimulation of conscious rats: implications for glycogen turnover. J. Neurochem. 2007, 102:466-478.
24. Walls A.B., et al. Robust glycogen shunt activity in astrocytes: effects of glutamatergic and adrenergic agents. Neuroscience 2009, 158:284-292.
25. Dinuzzo M., et al. The role of astrocytic glycogen in supporting the energetics of neuronal activity. Neurochem. Res. 2012, 37:2432-2438.
26. Hyder F., Rothman D.L. Quantitative fMRI and oxidative neuroenergetics. Neuroimage 2012, 62:985-994.
27. Mangia S., et al. Response to 'comment on recent modeling studies of astrocyte-neuron metabolic interactions': much ado about nothing. J. Cereb. Blood Flow Metab. 2011, 31:1346-1353.
28. Hall C.N., et al. Oxidative phosphorylation, not glycolysis, powers presynaptic and postsynaptic mechanisms underlying brain information processing. J. Neurosci. 2012, 32:8940-8951.
29. Pellerin L., Magistretti P.J. Sweet sixteen for ANLS. J. Cereb. Blood Flow Metab. 2012, 32:1152-1166.
30. Bauer D.E., et al. The glutamate transporter, GLAST, participates in a macromolecular complex that supports glutamate metabolism. Neurochem. Int. 2012, 61:566-574.
31. Dienel G.A. Astrocytic energetics during excitatory neurotransmission: what are contributions of glutamate oxidation and glycolysis?. Neurochem. Int. 2013, 63:244-258.
32. Newman L.A., et al. Lactate produced by glycogenolysis in astrocytes regulates memory processing. PLoS ONE 2011, 6:e28427.
33. Funfschilling U., et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 2012, 485:517-521.
34. Lee Y., et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 2012, 487:443-448.
35. Overgaard M., et al. Hypoxia and exercise provoke both lactate release and lactate oxidation by the human brain. FASEB J. 2012, 26:3012-3020.
36. Fox P.T., et al. Nonoxidative glucose consumption during focal physiologic neural activity. Science 1988, 241:462-464.
37. Devor A., et al. Stimulus-induced changes in blood flow and 2-deoxyglucose uptake dissociate in ipsilateral somatosensory cortex. J. Neurosci. 2008, 28:14347-14357.
38. Roy C.S., Sherrington C.S. On the regulation of the blood-supply of the brain. J. Physiol. 1890, 11:85-158.
39. Attwell D., et al. Glial and neuronal control of brain blood flow. Nature 2010, 468:232-243.
40. Vlassenko A.G., et al. Regulation of blood flow in activated human brain by cytosolic NADH/NAD+ ratio. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:1964-1969.
41. Vafaee M.S., et al. Oxygen consumption and blood flow coupling in human motor cortex during intense finger tapping: implication for a role of lactate. J. Cereb. Blood Flow Metab. 2012, 32:1859-1868.
42. Gordon G.R., et al. Brain metabolism dictates the polarity of astrocyte control over arterioles. Nature 2008, 456:745-749.
43. Gordon G.R., et al. Bidirectional control of arteriole diameter by astrocytes. Exp. Physiol. 2011, 96:393-399.
44. Wolf T., et al. Excessive oxygen or glucose supply does not alter the blood flow response to somatosensory stimulation or spreading depression in rats. Brain Res. 1997, 761:290-299.
45. Powers W.J., et al. Effect of stepped hypoglycemia on regional cerebral blood flow response to physiological brain activation. Am. J. Physiol. 1996, 270:H554-H559.
46. Nehlig A. Cerebral energy metabolism, glucose transport and blood flow: changes with maturation and adaptation to hypoglycaemia. Diabetes Metab. 1997, 23:18-29.
47. Leithner C., et al. Pharmacological uncoupling of activation induced increases in CBF and CMRO2. J. Cereb. Blood Flow Metab. 2010, 30:311-322.
48. Nicolakakis N., Hamel E. Neurovascular function in Alzheimer's disease patients and experimental models. J. Cereb. Blood Flow Metab. 2011, 31:1354-1370.
49. Lam C.K., et al. CNS regulation of glucose homeostasis. Physiology 2009, 24:159-170.
50. Grayson B.E., et al. Wired on sugar: the role of the CNS in the regulation of glucose homeostasis. Nat. Rev. Neurosci. 2013, 14:24-37.
51. Grill H.J., Hayes M.R. Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance. Cell Metab. 2012, 16:296-309.
52. Lam T.K., et al. Regulation of blood glucose by hypothalamic pyruvate metabolism. Science 2005, 309:943-947.
53. Filippi B.M., et al. Insulin activates Erk1/2 signaling in the dorsal vagal complex to inhibit glucose production. Cell Metab. 2012, 16:500-510.
54. Hayes M.R., et al. Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation. Cell Metab. 2011, 13:320-330.
55. Sandoval D.A., et al. Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes 2008, 57:2046-2054.
56. Bruning J.C., et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000, 289:2122-2125.
57. Chari M., et al. Glucose transporter-1 in the hypothalamic glial cells mediates glucose sensing to regulate glucose production in vivo. Diabetes 2011, 60:1901-1906.
58. Mounien L., et al. Glut2-dependent glucose-sensing controls thermoregulation by enhancing the leptin sensitivity of NPY and POMC neurons. FASEB J. 2010, 24:1747-1758.
59. Parton L.E., et al. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 2007, 449:228-232.
60. Kong D., et al. Glucose stimulation of hypothalamic MCH neurons involves K(ATP) channels, is modulated by UCP2, and regulates peripheral glucose homeostasis. Cell Metab. 2010, 12:545-552.
61. Kroemer G., et al. Autophagy and the integrated stress response. Mol. Cell 2010, 40:280-293.
62. Coupe B., et al. Loss of autophagy in pro-opiomelanocortin neurons perturbs axon growth and causes metabolic dysregulation. Cell Metab. 2012, 15:247-255.
63. Kaushik S., et al. Loss of autophagy in hypothalamic POMC neurons impairs lipolysis. EMBO Rep. 2012, 13:258-265.
64. Kaushik S., et al. Autophagy in hypothalamic AgRP neurons regulates food intake and energy balance. Cell Metab. 2011, 14:173-183.
65. Lynch R.M., et al. Localization of glucokinase gene expression in the rat brain. Diabetes 2000, 49:693-700.
66. Danial N.N., et al. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 2003, 424:952-956.
67. Joly-Amado A., et al. Hypothalamic AgRP-neurons control peripheral substrate utilization and nutrient partitioning. EMBO J. 2012, 31:4276-4288.
68. Aponte Y., et al. AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training. Nat. Neurosci. 2011, 14:351-355.
69. Wu Q., et al. Loss of GABAergic signaling by AgRP neurons to the parabrachial nucleus leads to starvation. Cell 2009, 137:1225-1234.
70. Yi C.X., Tschop M.H. Brain-gut-adipose-tissue communication pathways at a glance. Dis. Model Mech. 2012, 5:583-587.
71. King A., Gottlieb E. Glucose metabolism and programmed cell death: an evolutionary and mechanistic perspective. Curr. Opin. Cell Biol. 2009, 21:885-893.
72. Mergenthaler P., et al. Mitochondrial hexokinase II (HKII) and phosphoprotein enriched in astrocytes (PEA15) form a molecular switch governing cellular fate depending on the metabolic state. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:1518-1523.
73. Vaughn A.E., Deshmukh M. Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. Nat. Cell Biol. 2008, 10:1477-1483.
74. Majewski N., et al. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol. Cell 2004, 16:819-830.
75. Gimenez-Cassina A., et al. Mitochondrial hexokinase II promotes neuronal survival and acts downstream of glycogen synthase kinase-3. J. Biol. Chem. 2009, 284:3001-3011.
76. Herrero-Mendez A., et al. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat. Cell Biol. 2009, 11:747-752.
77. Cheung E.C., et al. Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:20491-20496.
78. Colell A., et al. GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell 2007, 129:983-997.
79. Ishitani R., Chuang D.M. Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:9937-9941.
80. Alavian K.N., et al. Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase. Nat. Cell Biol. 2011, 13:1224-1233.
81. Chen Y.B., et al. Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential. J. Cell Biol. 2011, 195:263-276.
82. Galluzzi L., et al. Non-apoptotic functions of apoptosis-regulatory proteins. EMBO Rep. 2012, 13:322-330.
83. Pascual J.M., et al. Brain glucose supply and the syndrome of infantile neuroglycopenia. Arch. Neurol. 2007, 64:507-513.
84. Leen W.G., et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 2010, 133:655-670.
85. Arsov T., et al. Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency. Epilepsia 2012, 53:e204-e207.
86. Arsov T., et al. Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann. Neurol. 2012, 72:807-815.
87. Neal E.G., et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008, 7:500-506.
88. Garriga-Canut M., et al. 2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat. Neurosci. 2006, 9:1382-1387.
89. Gimenez-Cassina A., et al. BAD-dependent regulation of fuel metabolism and K(ATP) channel activity confers resistance to epileptic seizures. Neuron 2012, 74:719-730.
90. Dirnagl U., et al. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999, 22:391-397.
91. Mergenthaler P., et al. Pathophysiology of stroke: lessons from animal models. Metab. Brain Dis. 2004, 19:151-167.
92. Dreier J.P. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat. Med. 2011, 17:439-447.
93. Vecchia D., Pietrobon D. Migraine: a disorder of brain excitatory-inhibitory balance?. Trends Neurosci. 2012, 35:507-520.
94. Sakowitz O.W., et al. Clusters of spreading depolarizations are associated with disturbed cerebral metabolism in patients with aneurysmal subarachnoid hemorrhage. Stroke 2013, 44:220-223.
95. Hoffmann U., et al. Glucose modulation of spreading depression susceptibility. J. Cereb. Blood Flow Metab. 2013, 33:191-195.
96. Kapogiannis D., Mattson M.P. Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol. 2011, 10:187-198.
97. Merlini M., et al. Vascular beta-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAbeta mice. Acta Neuropathol. 2011, 122:293-311.
98. Launer L.J., et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 2011, 10:969-977.
99. Borghammer P., et al. Glucose metabolism in small subcortical structures in Parkinson's disease. Acta Neurol. Scand. 2012, 125:303-310.
100. Corona J.C., et al. Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson's disease. J. Neurosci. Res. 2010, 88:1943-1950.
101. Skripuletz T., et al. De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected. Histol. Histopathol. 2011, 26:1585-1597.
102. Dalmau J., et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011, 10:63-74.
103. Leypoldt F., et al. Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J. Neurol. Neurosurg. Psychiatry 2012, 83:681-686.
104. Scheen A.J. Central nervous system: a conductor orchestrating metabolic regulations harmed by both hyperglycaemia and hypoglycaemia. Diabetes Metab. 2010, 36(Suppl. 3):S31-S38.
105. Scherbakov N., et al. Body weight after stroke: lessons from the obesity paradox. Stroke 2011, 42:3646-3650.
106. Harris H., Rubinsztein D.C. Control of autophagy as a therapy for neurodegenerative disease. Nat. Rev. Neurol. 2012, 8:108-117.
107. Sokoloff L., et al. The [14C]deoxyglucose method for measurement of local cerebral glucose utilization. Carbohydrates and Energy Metabolism 1989, 155-193. Humana Press. A. Boulton (Ed.).
108. Yao J., et al. Noninvasive photoacoustic computed tomography of mouse brain metabolism in vivo. Neuroimage 2012, 64C:257-266.
109. de Graaf R.A., et al. State of the art direct 13C and indirect 1H-[13C] NMR spectroscopy in vivo. A practical guide. NMR Biomed. 2011, 24:958-972.